Ufp Technologies Inc (UFPT) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket
 


Ufp Technologies Inc   (NASDAQ: UFPT)


Ufp Technologies Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Ufp Technologies Inc's ROI in the second quarter of 2026?
Ufp Technologies Inc achieved a return on average invested assets (ROI) of 12.29 % in its second quarter of 2026, this is above UFPT's average return on investment of 9.88%.
Ufp Technologies Inc invested over the 12 months ending in its second quarter of 2026 $588 million

ROI has improved compared to 11.86% in the first quarter of 2026, due to net income growth.

Within the Healthcare sector 68 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 628 to 681.

Definition and Formula of Return on Investment



Return On Investment (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 5.26 % 13.45 % 23.59 % 37.56 % 57.91 %
Y / Y Net Income Change TTM 7.74 % 8.12 % 47.58 % 124.39 % 395.13 %
Investment (TTM) in Millions 604 598 580 571 565
Return On Investment (TTM) 12.29 % 11.86 % 12.02 % 11.96 % 12.01 %
UFPT's Overall Ranking # 681 # 628 # 496 # 575 # 565
Seq. Investment Change TTM 1.65 % 1.83 % 1.23 % 0.47 % 9.55 %
Seq. Net Income Change TTM 5.35 % 0.46 % 1.77 % 0.03 % 5.72 %
Net Income (TTM) in Millions 72 69 68 67 67




Return On Investment UFPT's Ranking
Within: No.
Industry # 19
Sector # 69
Overall # 681

Return On Investment Statistics
High Average Low
14.68 %
9.88 %
6.28 %
(Jun 30 2023)   (Mar 31 2022)







Financial Statements
Ufp Technologies Inc's II. Quarter Investments $ 604 Millions UFPT's Balance sheet
Ufp Technologies Inc's II. Quarter Income $ 21 Millions Quarterly UFPT's Income Statement
UFPT's Income by Division See UFPT's Income by Division


UFPT Annual Return On Investment (Dec 31 2025)
2025
(Dec 31 2024)
2024
(Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
Total Investments in Millions 580 553 346 322 299
Y / Y Investment Growth 4.98 % 59.77 % 7.35 % 7.62 % 59.21 %
Net Income in Millions 68 59 45 42 16
Y / Y Net Income Growth 15.82 % 31.29 % 7.5 % 163.06 % 18.83 %
Annual Return On Investment 11.77 % 10.67 % 12.99 % 12.97 % 5.31 %


Annual Roi Comment
In the fiscal year 2025 ROI improved to 11.77 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
UFPT's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for UFPT's Competitors
Subscribers only: Roi for Ufp Technologies Inc's Suppliers
Subscribers only: Return On Investment for UFPT's Customers

Other Ratios
UFPT's Roa UFPT's Inventory Turnover Ratio UFPT's Growth Rates UFPT's Dividend Statistics
UFPT's Profitability Ratios UFPT's Asset Turnover Ratio UFPT's Dividend Growth
UFPT's Roe UFPT's Valuation Ratios UFPT's Financial Strength Ratios UFPT's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI
Acadia Pharmaceuticals Inc   31.05 %
Caredx Inc   29.42 %
Adma Biologics Inc   28.94 %
Protalix Biotherapeutics inc   25.72 %
Pro dex Inc   24.29 %
Innoviva Inc   23.33 %
Electromed Inc   23.18 %
Zevra Therapeutics Inc   22.90 %
Iradimed Corporation  22.57 %
Alnylam Pharmaceuticals Inc   22.10 %
Eton Pharmaceuticals Inc   21.31 %
Dexcom Inc   20.98 %
Healthcare Services Group Inc   20.93 %
Arcutis Biotherapeutics Inc   20.77 %
Chemed Corporation  20.13 %
Resmed Inc   20.01 %
Halozyme Therapeutics Inc   19.99 %
Vertex Pharmaceuticals Inc  19.97 %
Agilent Technologies inc   19.84 %
Illumina Inc   19.61 %
Puma Biotechnology Inc   19.60 %
United Therapeutics Corporation  19.53 %
Zoetis Inc   19.44 %
Krystal Biotech Inc   19.16 %
Carlisle Companies Incorporated  18.88 %
Neurocrine Biosciences Inc   17.51 %
Intuitive Surgical Inc   17.11 %
Theravance Biopharma inc   17.10 %
Standard Biotools Inc   16.38 %
Inspire Medical Systems inc   16.34 %


Date modified: 2026-09-26T07:14:06+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.